Imagine a key piece in the puzzle of Alzheimer’s disease: the Tau protein, notorious for forming twisted fibrils that disrupt brain function. The severity of these clumps directly correlates with the progression of the disease, making it a critical focus for researchers.
In its healthy state, the Tau protein plays a vital role in stabilizing microtubules, which are crucial for maintaining the structure of nerve cells. However, when these proteins undergo misfolding or other changes, they aggregate into tangles that can lead to neurodegenerative conditions such as Alzheimer's and frontotemporal dementia.
Traditionally, scientists have struggled to understand the structure of these Tau tangles because a staggering 80% of the protein resides in what is known as the 'fuzzy coat.' This outer layer is highly disordered, adding complexity to the analysis. Within this fuzzy coat lies a more rigid inner core composed of organized strands called beta sheets.
Recently, researchers at MIT have made significant strides by employing nuclear magnetic resonance (NMR) spectroscopy to investigate the elusive fuzzy coat surrounding Tau fibrils. This breakthrough marks the first time scientists have been able to discern the structure of this dynamic outer layer, an advance that could be pivotal in developing therapeutic strategies aimed at disrupting Tau accumulation in the brain.
"If we aim to break down these Tau fibrils using small-molecule drugs, those medications must effectively penetrate this fuzzy coat," explains Mei Hong, a professor of chemistry at MIT and a senior author of the study.
Jia Yi Zhang, a graduate student at MIT, served as the lead author on the paper published in the Journal of the American Chemical Society, with contributions from former MIT postdoc Aurelio Dregni.
The research team created new NMR techniques that enabled them to analyze the complete structure of the Tau protein, unlike previous methods that concentrated solely on the stiff core. In one innovative experiment, they magnetized protons within the most stable amino acids and measured how quickly this magnetization was transferred to the more mobile amino acids. This methodology allowed them to monitor the movement of magnetization between rigid and flexible regions of the protein, revealing the connections between these segments.
Through this approach, the researchers could estimate how close the rigid and mobile parts of the protein were to each other. They also assessed the varying degrees of motion among the amino acids within the fuzzy coat. "Our newly developed NMR technology allows us to capture both the dynamic fuzzy regions and the rigid core of a full-length Tau fibril," says Hong.
Interestingly, the structure of this particular Tau fibril resembles a burrito, with multiple layers of fuzzy coat enveloping the stiff core. The findings categorized the different parts of the protein based on their mobility: while the core remained rigid, the intermediate regions showed moderate movement, and the outermost layer displayed the highest degree of dynamism.
Notably, the most active segments within the fuzzy coat were rich in proline, an amino acid traditionally thought to be somewhat immobilized near the rigid core. Instead, these proline-rich areas were found to be quite mobile, suggesting that their positive charges repel the similarly charged amino acids forming the core, allowing for greater flexibility.
This new structural model sheds light on the mechanisms behind Tau tangling in the brain. Just as prions can induce healthy proteins to misfold, it is hypothesized that misfolded Tau proteins may bind to normal ones, acting as templates that encourage them to adopt abnormal shapes. This process could lead to normal Tau proteins either extending existing short fibrils or stacking onto one another, promoting the formation of longer aggregates.
The researchers are now eager to delve deeper, investigating whether they can prompt normal Tau proteins to form fibrils akin to those observed in Alzheimer's patients by utilizing misfolded Tau proteins as a template.
This study, which holds promising implications for future Alzheimer's therapies, was supported by grants from the National Institutes of Health.
